Dr Ibrahim Javed is currently an Enterprise Fellow (Senior Lecturer) and NHMRC Emerging Leadership Fellow at the Clinical and Health Sciences, University of South Australia. He is also an adjunct Senior Research Fellow at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland. He completed his doctoral studies at the Monash Institute of Pharmaceutical Sciences in 2020 and postdoctoral research at AIBN, The University of Queensland. He joined the University of South Australia in 2023 where he is now directing the laboratory of Gut-Brain Axis, Aging and Therapeutics. Research in Javed’s lab focuses on the gut-brain axis and its implications for aging and Dementia. His research team is working to unfold the specific role of bad/pathogenic gut bacteria in the aging paradigms and Dementia associated with Alzheimer’s and Parkinson’s diseases. His team has discovered and published the molecular details of how bad bacteria in the gut can trigger a younger onset (aged under 65) and accelerate Dementia and how the brain can develop Dementia when fighting with microbial biofilms in the gut – the infectious etiology of Dementia.
With this research trajectory, his vision is to develop towards a multifaceted therapeutic intervention for aging-associated diseases and Dementia. He also has a passion for public communication of scientific research and has published research stories in The Scientia Global Magazine UK, Insight+, The Medical Journal of Australia, interviews through ABC Radio, Radio 2 SM, Herald Sun and Channel 7 News. He is also an editorial board member of Nature Communications Biology journal.
Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital
We invite you to our first webcast of 2026, where Prof Andrew Sindone will provide an update on heart failure in primary care. Earn up to 4 hours CPD. RACGP & ACRRM accredited.
Clinical Articles
